GeneBioTech Co. ,Ltd stock price

진바이오텍KRX:086060 · KOSDAQ · Healthcare · sector #23
₩5,070+2.42%
2026-10-08 close
Loading chart…

GeneBioTech Co. ,Ltd's chart data is dated 2026-10-08. Recorded technical signals: VCP, Bollinger breakout. There are 7 published signal records.

GeneBioTech Co. ,Ltd last closed at ₩5,070 (+2.42%) on 2026-10-08. Signals today: VCP, Bollinger breakout. Listed on KOSDAQ. Trailing 12 months PER is 11.9×. Its overall grade ranks 60 of 308 stocks in Healthcare.

About this company

GeneBioTech Co. ,Ltd last closed at ₩5,070 (+2.42%) on 2026-10-08. Signals today: VCP, Bollinger breakout. Listed on KOSDAQ.

Details →

Reported results

Details →

Position in sector

Healthcare · Overall A · 60/308

Valuation grade B+

Details →

Recent filings

DART · received recent list, not a complete filing history. Factual information, not investment advice.

Details →

Related stocks

  • 대한사료Customer

    배합사료·축산 관련 제품의 주요 국내 고객/유통 채널 가능성이 큼

  • 카길코리아Competitor

    사료·축산 원료 및 동물영양 분야에서 경쟁 관계

  • 농협사료Customer

    국내 대형 사료 업체로 기능성 사료첨가제 수요처가 될 수 있음

Details →
About GeneBioTech Co. ,Ltd
What technical signals does GeneBioTech Co. ,Ltd (086060) have?
GeneBioTech Co. ,Ltd current technical signals: VCP, Bollinger breakout.
Is GeneBioTech Co. ,Ltd a cup-and-handle pattern?
No. GeneBioTech Co. ,Ltd has no valid Cup signal right now.
What published figures are available for GeneBioTech Co. ,Ltd?
Market cap: KRW 43.66B. Trailing 12 months PER: 11.9×. Latest quarter PBR: 0.78×. Dividend yield: 0.00%.

Like these rules? Backtest them.

Run this signal on this ticker in the free backtest builder — same window, no install.

Backtest this rule ↗

Major stocks in the same sector

2026-10-09 dataset

Turn what you saw on this name into a strategy

Ask Q about GeneBioTech Co. ,Ltd, or open the plan table on the main site.

From the names you found to a trading rule

Tell Q about the stocks you found to place orders with your conditions.

See plans ↗

GeneBioTech Co. ,Ltd notifications

Quantus Signal · live data · not investment advice · Privacy Policy